Exosomes derived from hypoxic mesenchymal stem cells restore ovarian function by enhancing angiogenesis

Area of Science:

• Regenerative Medicine
• Cell Biology
• Molecular Biology

Background:

• Human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-exosomes) show therapeutic potential.
• Engineering hucMSC-exosomes can enhance their therapeutic efficacy.
• Hypoxic preconditioning is explored to boost the angiogenic capacity of hucMSC-exosomes for ovarian conditions.

Purpose of the Study:

• To investigate if hypoxic preconditioning enhances the angiogenic potential of hucMSC-exosomes.
• To explore the underlying molecular mechanisms of enhanced angiogenesis.
• To assess the therapeutic effect in an experimental model of premature ovarian failure (POF).

Main Methods:

• Isolation and characterization of exosomes from normoxic (norm-Exos) and hypoxic (hypo-Exos) hucMSCs.
• In vitro assays assessing ROMEC proliferation, migration, and tube formation.
• In vivo studies in a rat model of POF using histology and immunohistochemistry.
• High-throughput miRNA sequencing, qRT-PCR, western blotting, bioinformatics, luciferase reporter assays, and gain/loss-of-function studies.

Main Results:

• Hypo-Exos significantly promoted ROMEC proliferation, migration, and tube formation in vitro.
• Hypoxia preconditioning strengthened the therapeutic angiogenic effect of hucMSC-exosomes in vivo.
• Exosomal miR-205-5p transfer was identified as the key mechanism, targeting the PTEN/PI3K/AKT/mTOR signaling pathway to enhance angiogenesis.

Conclusions:

• Hypoxia-conditioned hucMSC-exosomes enhance angiogenesis via miR-205-5p transfer.
• The PTEN/PI3K/AKT/mTOR pathway is modulated by exosomal miR-205-5p, promoting angiogenesis.
• This study provides a novel cell-free therapeutic strategy for POF treatment.